TriReme Medical - Drug-coated Balloon Technology - Ownership and Business Overview

Medical ProductsCompany

TriReme Medical - Drug-coated Balloon Technology Ownership

Who owns TriReme Medical - Drug-coated Balloon Technology?

TriReme Medical - Drug-coated Balloon Technology is owned by Genesis MedTech Group. It was acquired on August 31, 2020.

TriReme Medical - Drug-coated Balloon Technology Business Overview

Where is TriReme Medical - Drug-coated Balloon Technology headquartered?

TriReme Medical - Drug-coated Balloon Technology is headquartered in Pleasanton, California.

What sector is TriReme Medical - Drug-coated Balloon Technology in?

TriReme Medical - Drug-coated Balloon Technology is a medical products company.

Medical Products M&A Summary in 2020

Out of 60 sectors in the Mergr database, medical products ranked 12 in number of deals in 2020. The largest medical products acquisition in 2020 was Livongo Health - which was acquired by Teladoc Health for $18.5B.

Join Mergr to view all 217 acquisitions of medical products companies in 2020, including 32 acquisitions by private equity firms, and 185 by strategics.

TriReme Medical, Inc. - Drug-coated Balloon Technology

Pleasanton, California 94566
United States,

TriReme Medical, Inc.'s Drug-coated Balloon Technology provides patients suffering from peripheral vascular diseases a safer and more effective treatment than traditional balloon angioplasty.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.